Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranolazine for PVC Reduction in Ischemic Heart Disease
NCT02360397Phase 2Completed
- Sponsor
- Kent Hospital
- Start
- Dec 2014
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ranolazine in premature ventricular contractions (PVCs), Myocardial ischemia (MI), sponsored by Kent Hospital. Started Dec 2014; status: completed.
02
Drugs
ranolazine
03
Conditions
premature ventricular contractions (PVCs)Myocardial ischemia (MI)
Beyond the preview
Go deeper on NCT02360397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02360397.